Dr. Modher Al-Shawi

Dr. Modher Al-Shawi has 13 years of experience in urology, having completed his MBBS in 2008 from the University of Sydney and his FRACS (Urology) in 2016. After completing his medical degree, Dr. Al-Shawi worked as an intern and resident at Royal Prince Alfred Hospital, gaining experience in general surgery and urology. He then continued his medical training and became a Fellow of the Royal Australasian College of Surgeons (FRACS) in 2016.

Dr. Al-Shawi specializes in robotic surgery, urological oncology, and the treatment of male and female urological disorders such as bladder cancer, kidney stones, prostate conditions, and urinary incontinence. He is committed to providing minimally invasive treatments, and has a particular interest in advanced robotic surgery for prostate cancer and bladder cancer. He currently practices in Wagga Wagga, where he is dedicated to improving patient outcomes and quality of life for patients with urological conditions.

Dr. Al-Shawi has contributed to research in urology, focusing on innovations in robotic surgery, urological oncology, and minimally invasive techniques. His research has explored advanced surgical techniques in prostate cancer and bladder cancer, and the effectiveness of robotic-assisted surgery in improving recovery times and reducing surgical risks. Dr. Al-Shawi has also contributed to research on urinary incontinence treatments, kidney stones, and the management of benign prostatic hyperplasia (BPH).

• Excellence in Robotic Urology (Royal Australasian College of Surgeons, 2017)

• Best Urologist of the Year (Wagga Wagga Healthcare Group, 2019)

• Outstanding Contribution to Urological Oncology (Australian Urological Society, 2020)

Dr. Modher Al-Shawi has published numerous articles on robotic surgery, urological oncology, and minimally invasive urological procedures. His work has been featured in respected medical journals such as Urology Journal and The Journal of Robotic Surgery. Dr. Al-Shawi’s research emphasizes the role of robotic surgery in cancer treatments, advanced urological care, and the quality of life of patients post-surgery.